Loading data…
Explore company-wide revenue, income and balance-sheet facts directly from SEC filings.
$7.13M net income for the year ended January 3, 2026. These are reported results, not a forecast or a stock recommendation.
Latest-filed standard financial facts · USD
Bars show magnitude; labels retain the sign. Each observation covers a reported annual period of 330–400 days; transition years can differ.
Reported periods can differ from calendar years. Later filings may restate earlier figures. These are company-wide facts; product and geographic revenue segments are not included.
| Reported period | Reported value | Filed | Source |
|---|---|---|---|
| January 4, 2025 – January 3, 2026 | $248,970,345 | March 19, 2026 | 10-K/A ↗ |
| December 31, 2023 – December 28, 2024 | $272,751,967 | March 19, 2026 | 10-K/A ↗ |
| January 1, 2023 – December 30, 2023 | $258,857,380 | March 11, 2025 | 10-K ↗ |
| January 2, 2022 – December 31, 2022 | $279,265,146 | March 12, 2024 | 10-K ↗ |
| January 3, 2021 – January 1, 2022 | $246,522,823 | March 17, 2022 | 10-K ↗ |
| January 2, 2021 – December 31, 2021 | $246,522,823 | March 14, 2023 | 10-K ↗ |
| December 29, 2019 – January 2, 2021 | $197,614,590 | March 17, 2022 | 10-K ↗ |
| December 30, 2018 – December 28, 2019 | $251,742,619 | March 16, 2021 | 10-K ↗ |
One standard US-GAAP or IFRS concept is selected per metric, using USD only. Annual durations must be 330–400 days. Quarterly durations must be 70–110 days; year-to-date totals are excluded, and fourth quarters are never inferred by subtraction. Cash-flow quarters can therefore be sparse. Conflicting values filed on the same day are excluded. Latest-filed values are used, so these observations must not be treated as facts known in an earlier backtest.
Concept: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · Retrieved October 13, 2026
Response SHA-256: 432e8e95b4be9f2a696bb8b89808d8a34a25d1c21fa176249f7d51c71367a5de
Company-wide USD figures from SEC filings. Each card keeps its own reporting date; later filings can revise earlier results.